Funding fix: How new funding models are helping biotech startups launch

In the early 2000s, the process of forming a biotech company would typically go something like this: A scientist would discover or develop a novel asset, decide to form a company around it, then go about finding external funding and eventually build out the firm. Over the past two decades, the model has shifted. Read…

Read More

Atea Pharmaceuticals quadruples headcount, fueled by Roche joint venture

Atea pulled in $60.4 million in revenue in the second quarter, mostly attributable to a $50 million milestone payment from Roche for positive results from a Covid-19 antiviral the two are jointly developing. Atea says its antiviral pill causes a "rapid decline in viral load," limiting the replication of SARS-CoV-2 in the lungs and potentially…

Read More

Mass. business group AIM calls for statewide mask requirements

One of the state’s most powerful business lobbying groups is calling on the Baker administration to issue statewide mask requirements in light of the spread of the Delta variant. “It’d be great if government leaders would look to the CDC, look to the guidance from the public health community, and say, ‘This is what we…

Read More